131952-81-3Relevant academic research and scientific papers
Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action
Nishida, Haruyuki,Arikawa, Yasuyoshi,Hirase, Keizo,Imaeda, Toshihiro,Inatomi, Nobuhiro,Hori, Yasunobu,Matsukawa, Jun,Fujioka, Yasushi,Hamada, Teruki,Iida, Motoo,Nishitani, Mitsuyoshi,Imanishi, Akio,Fukui, Hideo,Itoh, Fumio,Kajino, Masahiro
supporting information, p. 3298 - 3314 (2017/05/29)
With the aim to find a novel long-lasting potassium-competitive acid blocker (P-CAB) that would perfectly overcome the limitations of proton pump inhibitors (PPIs), we tried various approaches based on pyrrole derivative 1b as a lead compound. As part of
Synthesis and dopamine D2-like receptor binding affinity of substituted 5-phenyl-pyrrole-3-carboxamides.
Pinna,Curzu,Sechi,Chelucci,Maciocco
, p. 542 - 550 (2007/10/03)
A series of 5-p-substituted phenyl-pyrrole-3-carboxamide derivatives was designed as hybrid analogs of the dopamine D2-like 5-phenyl-pyrrole and heterocyclic carboxamide antipsychotics. The title compounds were synthesized and evaluated for dopamine D2-like receptor by means of [3H]YM-09151-2 receptor binding assay. The compound bearing a 1-ethyl-2-methyl-pyrrolidine moiety as the basic part of 5-phenyl-pyrrole-3-carboxamide derivative 1a together with its 2-chloro analog 1f were found to possess affinity in the low micromolar range. Substituted phenyl-pyrrolecarboxamides containing groups such as F, Cl, NO2, CH3, at the 4-position of the phenyl ring, gave ligands with lower D2-like affinity.
4-fluorobenzoic compounds with 5-HT2 - and α1 -antagonistic activities
-
, (2008/06/13)
The invention relates to the compounds of general formula I: STR1 in which: m represents an integer from 2 to 4, n and p, which may be identical or different, each represent an integer from 1 to 3, q represents 0 or 1, and R represents: either a group of formula (A): STR2 or a radical of formula (B): STR3 or a 2,4-dioxo-1,2,3,4-tetrahydroquinazolinyl radical, on condition, however, that, in this case, n and p do not simultaneously represent the number 2, or a benzhydryloxy group, or a 1-oxophthalazinyl radical, or a 5-oxothiazolo[3,2-A]pyrimidinyl radical, or a group of formula C: STR4 their possible stereoisomers and their addition salts with a pharmaceutically acceptable inorganic or organic acid. The compounds of formula I are medicinal products with useful 5-HT2 - and α1 -antagonistic activities.
